|
시장보고서
상품코드
2106661
생체 징후 모니터링 기기 : 시장 인사이트, 경쟁 구도 및 시장 예측(-2034년)Vital Sign Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034 |
||||||
DelveInsight
개요:
- 생체 신호 모니터링 기기 시장은 2025년에 62억 7,000만 달러로 추산되며, 2034년까지 118억 3,000만 달러에 달할 것으로 예측됩니다. 이러한 성장의 배경에는 만성 질환 및 고혈압 유병률 증가, 원격 환자 모니터링 및 재택치료 프로그램의 확대, 그리고 AI를 활용한 조기 경보 매개변수가 단일 및 복합형 모니터링 기기에 통합되는 추세가 증가하고 있기 때문입니다.
- 전 세계 CRRT 장치 시장은 2026년부터 2034년까지의 예측 기간 동안 연평균 성장률(CAGR) 7.35%로 성장하고 있습니다.
- 제품 유형별로는 독립형 모니터링 기기 부문이 생체 신호 모니터링 기기 시장을 주도하고 있으며, 2025년에는 혈압 모니터링 기기가 약 48%의 점유율을 차지하며 주요 카테고리가 될 전망입니다.
- 혈압 모니터링 유형별로는 수은식 기기가 단계적으로 폐지되는 가운데, 자동 혈압계 부문이 가장 크고 가장 빠르게 성장하는 하위 부문으로 부상하고 있습니다.
- 최종 사용자별로는 2025년에 병원 부문이 생체 신호 모니터링 기기 시장을 독점하며 약 44%의 점유율을 차지했습니다.
- 북미는 2025년에 약 43%의 점유율을 차지하며 전 세계 생체 징후 모니터링 기기 시장의 매출을 주도했고, 지역별로는 전 세계에서 가장 높은 시장 점유율을 기록했습니다.
생체 징후 모니터링 장치는 병원, 진료소, 재택 간호 현장에서 혈중 산소 포화도, 혈압, 체온 등의 주요 생리학적 매개변수를 측정 및 추적하기 위해 사용되는 의료기기입니다. 이러한 장치에는 손가락용 맥박 산소 측정기나 자동 혈압계 등 단일 매개변수를 측정하는 단독형 기기부터, 중환자실, 수술 전후, 원격 환자 모니터링 환경에서 사용되는 여러 생체 신호를 동시에 측정하는 복합형 모니터링 장치에 이르기까지 다양한 유형가 있습니다. 이 시장은 제품 유형별로는 맥박 산소 측정기, 혈압 측정 장치, 체온 측정 장치 등의 단일 기능형 모니터링 장치와 복합형 모니터링 장치로 분류되며, 최종 사용자별로는 병원, 진료소, 재택 간호 환경 등으로 분류됩니다. 만성 질환의 부담 증가, 고령화, 수은 함유 기기의 단계적 폐지, 그리고 AI 지원·커넥티드·웨어러블 모니터링 기술의 보급에 힘입어, 생체 신호 모니터링 기기는 치료 전 과정에 걸쳐 필수적인 인프라로 자리 잡고 있습니다.
생체 신호 모니터링 기기 시장의 주요 시장 성장 촉진요인
- 전 세계적으로 만성 질환 및 심혈관 질환의 부담이 증가함에 따라 일상적인 생체 신호 모니터링 수요가 확대되고 있습니다. 세계보건기구(WHO)에 따르면, 심혈관 질환으로 인한 연간 사망자 수는 약 1,790만 명에 달하며, 그 대부분은 관리가 미흡한 고혈압과 관련이 있습니다.
- 전 세계적인 고령화와 당뇨병 및 호흡기 질환 유병률 증가에 따라, 모든 의료 현장에서 혈압, 산소 포화도, 체온 모니터링 빈도가 높아지고 있습니다.
- '재택 병원' 및 원격 환자 모니터링 프로그램의 확대에 따라 모니터링 실시 장소는 입원 병동에서 재택 간호 현장으로 이동하고 있으며, 이를 무선 연결형 맥박 산소 측정기 및 자동 혈압계가 뒷받침하고 있습니다.
- '미나마타 수은 협약'에 따른 수은 함유 혈압계 및 체온계의 규제 및 단계적 폐지에 따라, 디지털식, 아네로이드식 및 자동식 대체 기기로의 전환이 가속화되고 있습니다.
- 심방세동이나 오피오이드 유발성 호흡 억제 감지 등 AI를 활용한 파라미터가 맥박 산소 포화도 측정기나 혈압계에 통합됨에 따라, 단일 기기의 임상적 가치와 가격대가 확대되고 있습니다.
- Philips와 마시모의 모니터링 제휴 갱신, GE 헬스케어의 'Carevance' 출범, 메드트로닉과 마인드레이의 외래수술센터(ASC) 대상 제휴 등, 전략적 제휴와 플랫폼 확대를 통해 복합형 및 단일형 모니터링 기기의 유통 범위가 넓어지고 있습니다.
- 만성 질환의 부담, 원격 모니터링의 보급, 수은 사용 금지, 그리고 AI를 활용한 혁신이 맞물려 2034년까지 시장은 꾸준한 성장을 유지할 것으로 예측됩니다.
생체 징후 모니터링 기기 시장의 성장에 기여하는 요인
시장 성장 촉진요인
만성 질환 부담 증가 및 고혈압 유병률 상승
생체 신호 모니터링 기기 시장의 가장 일관된 촉진요인은 고혈압, 심혈관 질환 및 당뇨병의 전 세계적 부담 증가입니다. 세계보건기구(WHO)에 따르면, 심혈관 질환으로 인한 연간 사망자 수는 약 1,790만 명에 달하며, 그 대부분은 진단되지 않았거나 관리가 불충분한 고혈압과 관련이 있습니다. 정기적인 혈압, 산소 포화도, 체온 모니터링은 병원, 진료소, 그리고 가정에서 이러한 질환의 조기 발견과 지속적인 관리에 핵심적인 역할을 하고 있습니다. 고령화에 따라 만성 질환 유병률이 상승함에 따라, 생체 신호 모니터링의 빈도와 임상적 중요성도 그에 따라 높아져 2034년까지 시장 성장을 뒷받침하는 기반이 될 것입니다.
원격 환자 모니터링 및 재택 병원 프로그램의 확대
'재택 병원' 및 원격 환자 모니터링 프로그램의 급속한 확대로 인해, 생체 징후 모니터링의 상당 부분이 입원 병동에서 재택 간호 현장으로 이동하고 있습니다. 원격 모니터링에 대한 보험 급여 지원에 더해, 무선 맥박 산소 포화도 측정기, 자동 혈압계, 네트워크 연결형 체온계의 보급으로 인해 임상의는 기존의 병원 환경 밖에서도 환자의 상태를 추적하면서 치료의 연속성을 유지할 수 있게 되었습니다. 병원에서는 독립형 병상용 기기에서 전자 차트에 데이터를 직접 연동하는 연결형 기기의 생태계로 자본을 재분배하고 있으며, 이러한 추세로 인해 독립형 및 복합형 모니터링 기기 모두에서 대상 시장이 확대되고 있습니다.
시장 제약 요인
꾸준한 성장세를 보이고 있음에도 불구하고, 생체 징후 모니터링 기기 시장은 중대한 제약에 직면해 있습니다. 일부 소비자용 웨어러블 맥박 산소 포화도 측정기 및 혈압계에 대해서는 정확도와 신뢰성에 대한 우려가 여전히 남아 있으며, 다양한 피부 색소 침착 수준에서 맥박 산소 포화도 측정 정확도를 둘러싼 규제 당국의 감시도 강화되고 있습니다. 가격 압박과 재택·원격 모니터링 기기에 대한 보험 환급의 불균형은 비용에 민감한 시장에서의 도입을 제약하고 있으며, 특히 AI 기능을 갖춘 기기에 대한 엄격한 규제 승인 요건은 시장 출시까지의 기간을 길어지게 할 가능성이 있습니다. 건강 모니터링 분야에 진출하는 가전 제조업체와의 경쟁 심화로 인해 기존 기기 제조업체의 이익률은 압박을 받고 있습니다. 또한, 재택 간호 환경에서 환자와 간병인이 기기를 정확하고 원활하게 사용할 수 있는지 여부에 따라 결과가 달라진다는 점은 임상 등급의 병원용 기기에서는 찾아볼 수 없는 변동 요인을 초래하고 있습니다. 이러한 정확도, 가격, 규제, 경쟁과 관련된 압박이 복합적으로 작용하여, 근본적인 수요 동력은 여전히 견조함에도 불구하고 성장 속도는 둔화되고 있습니다.
자주 묻는 질문
목차
제1장 생체 징후 모니터링 기기 시장 : 서론
제2장 생체 징후 모니터링 기기 시장 : 주요 요약
제3장 생체 징후 모니터링 기기 시장 : 주요 요인 분석
제4장 AI, 지정학, 무역 및 경제 동향
제5장 규제 분석
제6장 Porter의 Five Forces 분석
제7장 생체 징후 모니터링 기기 시장 : 평가
제8장 생체 징후 모니터링 기기 시장 : 경쟁 구도
제9장 생체 징후 모니터링 기기 시장 : 스타트업의 자금조달 및 투자 동향
제10장 생체 징후 모니터링 기기 시장 : 기업 개요 및 제품 개요
제11장 KOL(Key Opinion Leader)의 견해
제12장 프로젝트 접근
제13장 DelveInsight에 대해
제14장 면책사항 및 문의
LSH 26.08.12Vital Sign Monitoring Devices Market Summary
Overview:
- The vital sign monitoring devices market is estimated at USD 6.27 billion in 2025 and is projected to reach USD 11.83 billion by 2034. Growth is anchored in rising chronic disease and hypertension prevalence, expanding remote patient monitoring and hospital-at-home programs, and increasing integration of AI-enabled early warning parameters into standalone and combined monitoring devices.
- The global CRRT Machines market is growing at a CAGR of 7.35% during the forecast period from 2026 to 2034.
- By product type, the standalone monitoring devices segment dominated the vital sign monitoring devices market, with blood pressure monitoring devices representing the leading category at approximately 48% share in 2025.
- By blood pressure monitor type, the automated blood pressure monitors segment is the leading and fastest-growing subsegment as mercury-based devices are phased out.
- By end-user, the hospitals segment dominated the vital sign monitoring devices market with an approximately 44% share in 2025.
- North America dominated the global vital sign monitoring devices market revenue with an approximately 43% share in 2025, representing the highest regional market share globally.
A vital sign monitoring device is a medical instrument used to measure and track core physiological parameters, including blood oxygen saturation, blood pressure, and body temperature, across hospitals, clinics, and home care settings. These devices range from single-parameter standalone instruments, such as fingertip pulse oximeters and automated blood pressure monitors, to combined monitoring devices that capture multiple vital signs simultaneously for use in intensive care, perioperative, and remote patient monitoring environments. The market is organized by product type across standalone monitoring devices, including pulse oximeters, blood pressure monitoring devices, and temperature monitoring devices, and combined monitoring devices; and by end-user across hospitals, clinics, homecare settings, and others. Driven by rising chronic disease burden, an aging population, the phase-down of mercury-containing devices, and growing adoption of AI-enabled, connected, and wearable monitoring technology, vital sign monitoring devices have become essential infrastructure across the continuum of care.
Vital Sign Monitoring Devices Market Key Growth Drivers
- The rising global burden of chronic and cardiovascular disease is expanding demand for routine vital sign monitoring, with the World Health Organization attributing approximately 17.9 million deaths annually to cardiovascular disease, the majority linked to poorly controlled hypertension.
- An aging global population and growing prevalence of diabetes and respiratory conditions are increasing the frequency of blood pressure, oxygen saturation, and temperature monitoring across care settings.
- Expanding hospital-at-home and remote patient monitoring programs are shifting monitoring volume from inpatient wards into homecare settings, supported by wireless, connected pulse oximeters and automated blood pressure monitors.
- Regulatory phase-down of mercury-containing sphygmomanometers and thermometers under the Minamata Convention on Mercury is accelerating the transition to digital, aneroid, and automated alternatives.
- Integration of AI-enabled parameters, including atrial fibrillation and opioid-induced respiratory depression detection, into pulse oximeters and blood pressure monitors is expanding the clinical value and price point of standalone devices.
- Strategic partnerships and platform expansions, including the renewed Philips-Masimo monitoring alliance, GE HealthCare's Carevance launch, and the Medtronic-Mindray ambulatory surgery center partnership, are broadening distribution of combined and standalone monitoring devices.
- The convergence of chronic disease burden, remote monitoring adoption, mercury phase-out, and AI-enabled innovation is expected to sustain steady growth in the market through 2034.
Key Companies in Vital Sign Monitoring Devices Market
The competitive landscape is led by the following active device manufacturers:
- Masimo
- Koninklijke Philips N.V.
- NIHON KOHDEN CORPORATION
- Nonin
- OMRON Corporation
- Baxter
- Medtronic
- Lepu Medical Technology (Beijing) Co., Ltd.
- GE HealthCare
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Factors Contributing to the Growth of the Vital Sign Monitoring Devices Market
Market Drivers
Rising Chronic Disease Burden and Hypertension Prevalence
The most consistent driver of the Vital Sign Monitoring Devices market is the rising global burden of hypertension, cardiovascular disease, and diabetes. The World Health Organization attributes approximately 17.9 million deaths annually to cardiovascular disease, a large share linked to undiagnosed or poorly controlled high blood pressure. Routine blood pressure, oxygen saturation, and temperature monitoring are central to early detection and ongoing management of these conditions across hospitals, clinics, and the home. As chronic disease prevalence rises alongside an aging population, the frequency and clinical importance of vital sign monitoring increases correspondingly, anchoring market growth through 2034.
Expansion of Remote Patient Monitoring and Hospital-at-Home Programs
The rapid scaling of hospital-at-home and remote patient monitoring programs is shifting a meaningful share of vital sign monitoring from inpatient wards into homecare settings. Reimbursement support for remote monitoring, combined with wireless pulse oximeters, automated blood pressure monitors, and connected thermometers, allows clinicians to track patients outside traditional hospital settings while maintaining continuity of care. Hospitals are reallocating capital from standalone bedside units toward connected device ecosystems that feed directly into electronic health records, a trend that is expanding the addressable market for both standalone and combined monitoring devices.
Market Restraints
Despite steady momentum, the Vital Sign Monitoring Devices market faces material constraints. Accuracy and reliability concerns persist for certain consumer-grade wearable pulse oximeters and blood pressure monitors, and regulatory scrutiny has intensified around pulse oximetry accuracy across different skin pigmentation levels. Pricing pressure and uneven reimbursement for home and remote monitoring devices constrain adoption in cost-sensitive markets, while stringent regulatory clearance requirements, particularly for AI-enabled features, can lengthen time to market. Intensifying competition from consumer electronics companies entering the health-monitoring space is compressing margins for legacy device makers, and dependence on accurate, low-friction patient or caregiver use in homecare settings introduces variability that clinical-grade hospital devices do not face. Together, these accuracy, pricing, regulatory, and competitive pressures temper the pace of growth even as underlying demand drivers remain firmly intact.
Vital Sign Monitoring Devices Market Segment Analysis
The Vital Sign Monitoring Devices by Market by Product Type (Standalone Monitoring Devices [Pulse Oximeter {Fingertip Pulse Oximeters, Handheld Pulse Oximeters, Bench-Top Pulse Oximeters, and Wearable Pulse Oximeters}, Blood Pressure Monitoring Devices {Mercury Blood Pressure Monitors, Aneroid Blood Pressure Monitors, Automated Blood Pressure Monitors}, Temperature Monitoring Devices {Digital Thermometers, Infrared Thermometers, and Others}, and Others] and Combined Monitoring Devices), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of World).
By Product Type
Dominant Subsegment: Machines.
Dominant: Blood Pressure Monitoring Devices ~ 48%
The Blood Pressure Monitoring Devices segment accounted for approximately 48% of the Vital Sign Monitoring Devices market in 2025. Blood pressure monitors are the leading product category because hypertension screening and management are required across nearly every clinical encounter, from routine outpatient visits to intensive care, and because home blood pressure monitoring has become a standard of care for hypertension management. Within the segment, Automated Blood Pressure Monitors are the leading and fastest-growing subtype as mercury and aneroid devices are phased out under mercury-reduction regulations and replaced with digital, oscillometric, and increasingly AI-enabled automated monitors. Pulse Oximeters represent the fastest-growing product category overall, propelled by rising demand for wearable and fingertip devices in home and ambulatory settings, while Temperature Monitoring Devices maintain steady demand led by infrared, non-contact thermometers. Combined Monitoring Devices, which capture multiple vital signs on a single platform, are gaining share in hospital ICUs, operating rooms, and perioperative settings, but the breadth and recurrence of blood pressure monitoring across all care settings secures the standalone blood pressure monitor segment's leadership across the forecast period.
By End-User
Dominant Subsegment: Hospitals.
Dominant: Hospitals ~ 44%
The hospitals segment accounted for approximately 44% of the vital sign monitoring devices market in 2025. Hospitals remain the leading end-user because vital sign monitoring is a mandatory, continuous component of inpatient care across emergency departments, intensive care units, general wards, and operating rooms, requiring high volumes of both standalone and combined monitoring devices. Clinics represent a steady, recurring end-user segment supporting routine outpatient screening, while Homecare Settings are the fastest-growing end-user category as hospital-at-home programs, remote patient monitoring reimbursement, and consumer-grade wearable pulse oximeters and blood pressure monitors expand access to monitoring outside traditional facilities. Nonetheless, the scale, regulatory requirements, and continuous monitoring needs of hospitals secure their leadership across the forecast period.
Vital Sign Monitoring Devices Market Region Analysis
Dominant Region: North America
Dominant: North America ~ 43% (Largest)
North America accounted for approximately 43% of the global vital sign monitoring devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects advanced hospital infrastructure, high adoption of remote patient monitoring and hospital-at-home programs, strong reimbursement support, and the concentrated presence of leading manufacturers including Masimo, GE HealthCare, Medtronic, and Baxter. The United States hosts the largest base of AI-enabled monitoring device deployment, supported by FDA clearances such as OMRON's AI-powered AFib-detection blood pressure monitors and Masimo's AI-enabled respiratory depression detection. Continued investment in connected monitoring platforms and strategic partnerships among top-tier device makers anchor the region's continued leadership across the forecast period.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the vital sign monitoring devices market. The region's elevated CAGR is driven by rising cardiovascular and chronic disease incidence, rapid expansion of hospital infrastructure, and growing government healthcare investment across China, Japan, India, South Korea, and Australia. China is expanding hospital and homecare monitoring device adoption, Japan's aging population is driving demand for connected home blood pressure and temperature monitoring, and India is scaling low-cost manufacturing and distribution of standalone monitoring devices. The combination of rising disease burden, healthcare infrastructure build-out, and increasing consumer adoption of wearable pulse oximeters and blood pressure monitors positions Asia-Pacific as the principal source of incremental growth over the forecast period.
Regional Commentary
North America
North America accounted for approximately 43% of the global Vital Sign Monitoring Devices market revenue in 2025. The United States dominates on the strength of its hospital infrastructure, remote patient monitoring reimbursement, and concentrated presence of leading manufacturers, while continued AI-enabled product clearances and strategic partnerships reinforce its leadership.
Europe
Europe is a large and advanced regional market, supported by established regulatory frameworks under the EU Medical Device Regulation, well-developed hospital networks, and an aging population driving sustained demand for both standalone and combined monitoring devices. Regional mercury-reduction regulation continues to accelerate the shift from mercury-based to digital and automated blood pressure and temperature monitors across Germany, France, the United Kingdom, Italy, and Spain.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by rising chronic disease incidence, rapid hospital infrastructure build-out, and growing consumer adoption of wearable and connected monitoring devices across China, Japan, India, South Korea, and Australia. Government healthcare investment and expanding homecare monitoring adoption are accelerating regional growth.
Rest of World
The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital and primary-care infrastructure, rising demand for blood pressure and oxygen saturation monitoring amid growing chronic disease burden, and gradual adoption of digital and automated devices in place of mercury-based instruments are broadening access, while international distribution partnerships support regional capacity build-out.
Vital Sign Monitoring Devices Market Competitive Landscape
The Vital Sign Monitoring Devices market is classified as Fragmented. A group of globally integrated players with broad hospital and homecare distribution, including Masimo, Koninklijke Philips N.V., GE HealthCare, Medtronic, and Shenzhen Mindray Bio-Medical Electronics Co., Ltd., anchor the top tier, while specialized and regionally strong providers such as OMRON Corporation, NIHON KOHDEN CORPORATION, Nonin, Baxter, and Lepu Medical Technology (Beijing) Co., Ltd. compete through product specialization, consumer-channel reach, and regional manufacturing scale, alongside a long tail of smaller standalone-device manufacturers.
The competitive landscape can be evaluated across the following dimensions:
- Market concentration: Fragmented, with a handful of globally integrated players competing alongside numerous specialized and regional standalone-device manufacturers.
- Leading players: Masimo, Koninklijke Philips N.V., GE HealthCare, Medtronic, and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. anchor the top tier through broad hospital and combined-device portfolios.
- Geographic reach: Leaders operate global distribution networks spanning hospital, clinic, and consumer retail channels; OMRON's home blood pressure monitors are distributed across more than 100 countries.
- Product portfolio strength: Top players offer end-to-end standalone and combined monitoring devices spanning pulse oximetry, blood pressure, temperature, and multi-parameter platforms.
- Technology access: Ownership of proprietary sensing technologies, such as Masimo's SET pulse oximetry and OMRON's IntelliSense AFib algorithm, is a decisive competitive advantage.
- Strategic partnerships: Tie-ups between hardware and technology leaders, such as the renewed Philips-Masimo alliance and the Medtronic-Mindray ambulatory surgery center partnership, extend reach and technology access.
- M&A and alliance activity: Active partnership expansion, including Medtronic's broadened GE HealthCare and Mindray alliances, underscores the strategic value of combined distribution and technology access.
- Manufacturing capabilities: Consumer-scale manufacturing for standalone devices and regulated GMP production for hospital-grade combined monitors are key competitive moats.
- Innovation focus: AI-enabled early warning and arrhythmia detection, connected and wearable form factors, and the phase-out of mercury-based devices are the leading edges of innovation.
Vital Sign Monitoring Devices Market Recent Developmental Activities
In October 2025, GE HealthCare received CE mark for its Carevance patient monitor, a cost-effective, clinically reliable monitoring solution designed for broader hospital accessibility across Europe. Strategic significance: Expands GE HealthCare's addressable hospital monitoring segment with a validated, lower-cost platform.
In January 2026, Medtronic and GE HealthCare announced an expansion of their long-running patient monitoring alliance to bring Medtronic's Nellcor pulse oximetry technology to more healthcare settings.
Vital Sign Monitoring Devices Market Segmentation
Vital Sign Monitoring Devices Market by Product Type
- Standalone Monitoring Devices
- Pulse Oximeter
- Fingertip Pulse Oximeters
- Handheld Pulse Oximeters
- Bench-Top Pulse Oximeters
- Wearable Pulse Oximeters
- Blood Pressure Monitoring Devices
- Mercury Blood Pressure Monitors
- Aneroid Blood Pressure Monitors
- Automated Blood Pressure Monitors
- Temperature Monitoring Devices
- Digital Thermometers
- Infrared Thermometers
- Others
- Others
- Combined Monitoring Devices
Vital Sign Monitoring Devices Market by End User
- Hospitals
- Clinics
- Homecare Settings
- Others
Vital Sign Monitoring Devices Market by Geography
- North America Vital Sign Monitoring Devices Market
- United States Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- Canada Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- Mexico Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- Europe Vital Sign Monitoring Devices Market
- Germany Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- United Kingdom Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- France Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- Italy Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- Spain Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- Rest of Europe Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- Asia-Pacific Vital Sign Monitoring Devices Market
- China Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- Japan Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- India Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- Australia Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- South Korea Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- Rest of Asia-Pacific Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- Rest of the World (RoW) Vital Sign Monitoring Devices Market
- Middle East Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- Africa Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- South America Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
Key Takeaways from the Vital Sign Monitoring Devices Market Report Study
- Market size analysis for the current vital sign monitoring devices market size (2025), and market forecast for 9 years (2026 to 2034).
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
- Key companies dominating the global vital sign monitoring devices market.
- Various opportunities available for competitors in the vital sign monitoring devices market space.
- What are the top-performing segments in 2025? How will these segments perform in 2034?
- Which are the top-performing regions and countries in the current vital sign monitoring devices market scenario?
- Which are the regions and countries where companies should concentrate their opportunities for vital sign monitoring devices market growth in the future?
Target audience who can benefit from this vital sign monitoring devices market report study
- Vital sign monitoring devices product providers
- Research organizations and consulting companies
- Vital sign monitoring devices-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and traders dealing in vital sign monitoring devices
- Various end-users who want to know more about the vital sign monitoring devices market and the latest technological developments in the vital sign monitoring devices market.
Frequently Asked Questions:
Q1. What is the growth rate of the vital sign monitoring devices market?
The vital sign monitoring devices market is projected to expand at a CAGR of 7.35% during the forecast period from 2026-2034.
Q2. What is the market size of the vital sign monitoring devices market?
The vital sign monitoring devices market is estimated at USD 6.27 billion in 2025 and is projected to reach USD 11.83 billion by 2034.
Q3. Which region dominates the Vital Sign Monitoring Devices market?
North America dominated the Vital Sign Monitoring Devices market with an approximately 43% share of global revenue in 2025, supported by advanced hospital infrastructure, strong reimbursement for remote patient monitoring, and the concentrated presence of leading manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.
Q4. What are the key drivers of the vital sign monitoring devices market?
The principal drivers are the rising global burden of chronic and cardiovascular disease; expansion of remote patient monitoring and hospital-at-home programs; regulatory phase-out of mercury-based blood pressure and temperature monitors; integration of AI-enabled parameters such as atrial fibrillation and respiratory depression detection; and strategic partnerships among leading manufacturers expanding combined-device distribution.
Q5. Who are the major players in the vital sign monitoring devices market?
The major players include Masimo, Koninklijke Philips N.V., NIHON KOHDEN CORPORATION, Nonin, OMRON Corporation, Baxter, Medtronic, Lepu Medical Technology (Beijing) Co., Ltd., GE HealthCare, and Shenzhen Mindray Bio-Medical Electronics Co., Ltd., among other active manufacturers profiled in the Competitive Landscape section. Masimo, Koninklijke Philips N.V., GE HealthCare, Medtronic, and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. lead through broad hospital distribution and combined-device technology.
Table of Contents
1. Vital Sign Monitoring Devices Market Report Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.3 Market Assumptions
2. Vital Sign Monitoring Devices Market Executive Summary
- 2.1 Market at a Glance
3. Vital Sign Monitoring Devices Market Key Factors Analysis
- 3.1 Vital Sign Monitoring Devices Market Drivers
- 3.1.1 Rising Chronic Disease Burden and Hypertension Prevalence
- 3.1.2 Expansion of Remote Patient Monitoring and Hospital-at-Home Programs
- 3.1.3 Phase-Out of Mercury-Based Devices
- 3.1.4 Integration of AI-Enabled Monitoring Parameters
- 3.2 Vital Sign Monitoring Devices Market Restraints and Challenges
- 3.2.1 Accuracy and Reliability Concerns in Consumer-Grade Devices
- 3.2.2 Pricing Pressure and Uneven Reimbursement
- 3.2.3 Regulatory Complexity for AI-Enabled Features
- 3.3 Vital Sign Monitoring Devices Market Opportunities
- 3.3.1 AI-Enabled Early Warning and Arrhythmia Detection Scale-Up
- 3.3.2 Homecare and Ambulatory Surgery Center Expansion
4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
5. Regulatory Analysis
- 5.1 United States
- 5.2 Europe
- 5.3 Japan
- 5.4 China
6. Vital Sign Monitoring Devices Market Porter's Five Forces Analysis
- 6.1 Bargaining Power of Suppliers
- 6.2 Bargaining Power of Buyers
- 6.3 Threat of New Entrants
- 6.4 Threat of Substitutes
- 6.5 Competitive Rivalry
7. Vital Sign Monitoring Devices Market Assessment
- 7.1 By Product Type
- 7.1.1 Standalone Monitoring Devices
- 7.1.1.1 Pulse Oximeter
- 7.1.1.1.1 Fingertip Pulse Oximeters
- 7.1.1.1.2 Handheld Pulse Oximeters
- 7.1.1.1.3 Bench-Top Pulse Oximeters
- 7.1.1.1.4 Wearable Pulse Oximeters
- 7.1.1.2 Blood Pressure Monitoring Devices
- 7.1.1.2.1 Mercury Blood Pressure Monitors
- 7.1.1.2.2 Aneroid Blood Pressure Monitors
- 7.1.1.2.3 Automated Blood Pressure Monitors
- 7.1.1.3 Temperature Monitoring Devices
- 7.1.1.3.1 Digital Thermometers
- 7.1.1.3.2 Infrared Thermometers
- 7.1.1.3.3 Others
- 7.1.1.4 Others
- 7.1.2 Combined Monitoring Devices
- 7.1.1 Standalone Monitoring Devices
- 7.4 By End-User
- 7.2.1 Hospitals
- 7.2.2 Clinics
- 7.2.3 Homecare Settings
- 7.2.4 Others
- 7.3 By Geography
- 7.3.1 North America
- 7.3.1.1 United States Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.1.2 Canada Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.1.3 Mexico Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.2 Europe
- 7.3.2.1 Germany Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.2.2 United Kingdom Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.2.3 France Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.2.4 Italy Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.2.5 Spain Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.2.6 Rest of Europe Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.3 Asia-Pacific
- 7.3.3.1 China Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.3.2 Japan Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.3.3 India Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.3.4 Australia Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.3.5 South Korea Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.3.6 Rest of Asia-Pacific Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.4 Rest of World
- 7.3.4.1 Middle East Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.4.2 Africa Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.4.3 South America Vital Sign Monitoring Devices Market Size in USD million (2023-2034)
- 7.3.1 North America
8. Vital Sign Monitoring Devices Market Competitive Landscape
- 8.1 Market Concentration and Structure
- 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)
9. Vital Sign Monitoring Devices Market Startup Funding and Investment Trends
10. Vital Sign Monitoring Devices Market Company and Product Profiles
- 10.1 Masimo
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Service Portfolio
- 10.1.5 Strategic Initiatives / Entropy
- 10.2 Koninklijke Philips N.V.
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Portfolio
- 10.2.5 Strategic Initiatives / Entropy
- 10.3 NIHON KOHDEN CORPORATION
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Portfolio
- 10.3.5 Strategic Initiatives / Entropy
- 10.4 Nonin
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Portfolio
- 10.4.5 Strategic Initiatives / Entropy
- 10.5 OMRON Corporation
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Portfolio
- 10.5.5 Strategic Initiatives / Entropy
- 10.6 Baxter
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Portfolio
- 10.6.5 Strategic Initiatives / Entropy
- 10.7 Medtronic
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Portfolio
- 10.7.5 Strategic Initiatives / Entropy
- 10.8 Lepu Medical Technology (Beijing) Co., Ltd.
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Portfolio
- 10.8.5 Strategic Initiatives / Entropy
- 10.9 GE HealthCare
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Portfolio
- 10.9.5 Strategic Initiatives / Entropy
- 10.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Portfolio
- 10.10.5 Strategic Initiatives / Entropy
For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.
